Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study
2016; Oxford University Press; Volume: 10; Issue: 8 Linguagem: Inglês
10.1093/ecco-jcc/jjw048
ISSN1876-4479
AutoresLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, R. D’Incà, Fabiana Castiglione, Claudio Papi, Erika Angelucci, Marco Daperno, Filippo Mocciaro, Gabriele Riegler, Walter Fries, Gianmichele Meucci, Patrizia Alvisi, Luisa Spina, Sandro Ardizzone, C. Petruzziello, Alessandra Ruffa, Anna Kohn, Maurizio Vecchi, Luisa Guidi, Roberto Di Mitri, Sara Renna, Emma Calabrese, Francesca Rogai, Alessandra Rossi, Ambrogio Orlando, Francesco Pallone,
Tópico(s)Autoimmune and Inflammatory Disorders
ResumoBackground and Aims:Cancer risk in inflammatory bowel disease [IBD] is still debated. In a prospective, multicentre, nested case-control study, we aimed to characterise incident cases of cancer in IBD. The role of immunomodulators vs clinical characteristics of IBD as risk factors for cancer was also investigated.
Referência(s)